History | Daratumumab with bortezomib and dexamethasone for previously treated multiple myeloma | Guidance | NICE

History

Expected publication

Supporting documentation Register of interests (PDF 157 KB)

Published:

04 December 2023

Final draft guidance

Final draft guidance
Committee papers (PDF 3.18 MB)

Published:

24 April 2023
Public committee slides (PowerPoint 2.95 MB)

Published:

24 April 2023
Final appraisal document (PDF 277 KB)

Published:

24 April 2023

Invitation to participate

Final scope (PDF 186 KB)

Published:

01 July 2022
Final stakeholder list (PDF 170 KB)

Published:

04 July 2022